YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Medtronic Pacemakers
Medtronic Pacemakers
Medtronic Inc. announced they are advising physicians of a potential problem in a small number of its Sigma pacemakers in which wires may separate from a circuit. No deaths or injuries were reported, though some users suffered dizziness or fainting, according to the Fridley-based medical-devices maker. An estimated 28,000 pacemakers, including 6,650 in the U.S., are covered by the advisory, which Medtronic said could be classified by the U.S. Food and Drug Administration as a recall.Medtronic said the defect took place when a solvent used to clean pacemaker wires degraded them over time, causing the wires to break from the circuitry in 19 devices. Pacemakers help spark the heart to achieve a steady, timely beat. The company estimates that 47 to 84 units, all made between November 2001 and August 2004, could be affected over the 10-year life of the units.
"The risk to patients is extremely low, but we are alerting physicians to the issue to ensure they are aware of the situation and can appropriately care for their patients," said Steve Mahle, president of Medtronic's cardiac rhythm management division.
Although the company doesn't recommend replacing the devices "prior to normal elective replacement,'' it added that this decision should be left up to the doctor based on each patients unique circumstances.
If you or a loved one suffered injuries from a Medtronic Pacemaker, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney.
Medtronic PacemakersRSS Feed
Medtronic Warned on SynchroMed Drug Pumps, MiniMed Insulin Pump Manufacturing
Jun 25, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. has received a warning letter regarding its SynchroMed II Drug Pumps and MiniMed Paradigm Insulin Pump. In the letter, the Food & Administration (FDA), cites Medtronic for taking too long to recall the SynchroMed pumps. The letter also said that an inspection conducted last year at the Puerto Rican plant where both pumps were made found that Medtronic failed to establish and maintain quality controls in manufacturing.SynchroMed II pumps are...
Medtronic Issues Class I Recall for Some Pacemakers
Jun 11, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. is issuing a Class I recall for certain Medtronic Kappa and Sigma pacemakers because of wiring issues that may cause the devices to fail. A Class I recall is the Food & Drug Administration's (FDA) most serious recall action, and is issued when there is a reasonable probability that the use of the device will cause serious adverse health consequences or death.The Medtronic pacemakers involved in this recall include: Kappa Series 600/700/900Sigma Series...
Medtronic Announces Job Cuts, Restructuring
May 7, 2008 | Parker Waichman Alonso LLP
Still struggling in the wake of last year's Sprint Fidelis Defibrillator Lead recall, medical device maker Medtronic Inc. says it plans to cut 1,100 jobs worldwide as part of a restructuring plan. Medtronic's business has been hurt, not just by the Sprint Fidelis recall, but by the declining worldwide demand for implantable defibrillators, which has been shrinking since Medtronic and competitors recalled faulty products in 2005.Medtronic suspended sales of the Sprint Fidelis Leads in...
Medtronic Unit Agrees to Consent Decree
Apr 28, 2008 | Parker Waichman Alonso LLP
An agreement has been reached by a unit of Medtronic Inc. on a consent decree with the U.S. Food and Drug Administration (FDA) over quality system improvements for its external defibrillators. The agreement—which is subject to court approval—addresses concerns raised by the FDA during inspections and outlines actions Medtronic's Physio-Control subsidiary must take to resume unrestricted distribution of the portable electronic devices. Physio-control is a maker of external...
Medtronic Pushes for Expansion of 'Sunshine Act'
Feb 27, 2008 | Parker Waichman Alonso LLP
Medical device maker Medtronic Inc. said on Tuesday that a proposed bill aimed at curbing inappropriate relationships between companies and physicians should require all device makers to be included, not just big ones. The proposed "Sunshine Act" was introduced earlier this year by Senators Chuck Grassley and Herb Kohl and would require companies to publicly disclose—via the Internet—certain payments made to physicians for help with product development, research, and...
Medtronic Pacemakers
Quick Facts
Medtronic Pacemakers Reference Guide
Manufacturer
Medtronic
Status
11/29/05 Advisory
Complications
Wires separate from circuit
Models Affected
April 2001 - December 2003
Marquis VR/DR
Maximo VR/DR
InSync I/II/III Marquis
InSync III Protect CRT-D
Related Topics
Guidant Pacemakers
Guidant Implantable Pacemaker
Defective Medical Devices
Medtronic
Status
11/29/05 Advisory
Complications
Wires separate from circuit
Models Affected
April 2001 - December 2003
Marquis VR/DR
Maximo VR/DR
InSync I/II/III Marquis
InSync III Protect CRT-D
Related Topics
Guidant Pacemakers
Guidant Implantable Pacemaker
Defective Medical Devices
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS